Clinical Trial Update: MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update reporting MRI and MR spectroscopy imaging in men taking dutasteride for benign prostatic hyperplasia and low-risk prostate cancer; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostate Cancer

Drugs mentioned

• Dutasteride (Avodart) (dutasteride)

Snippet

Sponsor: University of California, San Francisco | Conditions: Nonmalignant Neoplasm, Prostate Cancer | NA | Status: COMPLETED | Results posted: 2014-01-17